Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Increased Plan B Access Just One Factor In Abortion Reduction – Wood

This article was originally published in The Tan Sheet

Executive Summary

A "huge gulf" exists "between making emergency contraception available over the counter and actually seeing a reduction in nationwide abortion rates," NEJM Editor Jeffrey Drazen and FDA Nonprescription Drugs Advisory Committee Chair Alastair Wood contend

You may also be interested in...



Plan B Public Debate May Spotlight Smoking Cessation Age Limit Precedent

FDA's age-based approval for OTC sale of smoking-cessation drugs sets a precedent that addresses the agency's concerns about age-related marketing of Barr Labs' emergency contraceptive Plan B, according to NCI Consulting President Sue Coleman

Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands

Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12

Physicians Formula Continues To Solve Real, Perceived Problems Into 2008

Physicians Formula, which has found success distinguishing itself as a "problem/solution brand" since its inception, plans to remain competitive in 2008 and beyond with a three-pronged plan of attack, according to CEO Ingrid Jackel

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel